Ticker Scorecard - SGMT Basics Company: Sagimet Biosciences Inc. Series A IPO Date: July 14, 2023 Sector: Healthcare Industry: Biotech Market Cap: $132.64M Activated in VL: True Average Daily Range Avg Daily Range: $0.30 | 5.12% Avg Daily Range (30 D): $0.21 | 4.61% Avg Daily Range (90 D): $0.22 | 4.46% Institutional Daily Volume Avg Daily Volume: .71M Avg Daily Volume (30 D): .99M Avg Daily Volume (90 D): .84M Trade Size Avg Trade Size (Sh.): 138 Avg Trade Size (Sh.) (30 D): 145 Avg Trade Size (Sh.) (90 D): 148 Institutional Trades Total Inst.Trades: 51 Avg Inst. Trade: $1.45M Avg Inst. Trade (30 D): $.6M Avg Inst. Trade (90 D): $.55M Avg Inst. Trade Volume: .25M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $3.2M Avg Closing Trade (30 D): $.53M Avg Closing Trade (90 D): $.53M Avg Closing Volume: 580.39K     News Oct 1, 2024 @ 4:05 AM Sagimet Biosciences to Present at the H.C. Wainwri... Source: N/A Jun 6, 2024 @ 9:00 AM Sagimet Biosciences Presents Data from ITT and F3 ... Source: Sagimet Biosciences Inc. May 16, 2024 @ 12:20 PM Alibaba To Rally Over 13%? Here Are 10 Top Analyst... Source: Avi Kapoor May 16, 2024 @ 12:00 PM Sagimet Biosciences to Host Virtual Investor and A... Source: Sagimet Biosciences Inc. May 6, 2024 @ 12:00 PM Sagimet Biosciences Announces Appointment of Thier... Source: Sagimet Biosciences Inc. Financials   TTM Q2 2024 Q1 2024 Basic EPS $-.45 $-.25 $-.23 Diluted EPS $-.45 $-.25 $-.23 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -14.62M $ -8.12M $ -6.63M Operating Income / Loss $ -16.9M $ -10.59M $ -8.77M Cost of Revenue $ $ $ Net Cash Flow $ -18.95M $ -80.82M $ 101.64M PE Ratio